These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18779628)

  • 1. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
    de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
    Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure in a 17-year-old female with ALL receiving escalating intravenous methotrexate without leukovorin.
    Kanwar VS; Pearce J
    Pediatr Blood Cancer; 2007 Aug; 49(2):216;author reply 219. PubMed ID: 16786587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Managing methotrexate toxicity: a case report].
    Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
    Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R; Rentsch K; Di Paolo E; Popovic MB
    Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure.
    Castro M
    J Clin Oncol; 2003 Nov; 21(21):4066. PubMed ID: 14581433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Chai-ling-tang (Sairei-to) for methotrexate concentration degradation delay by methotrexate high-dose therapy].
    Utsuki S; Oka H; Suzuki S; Sato S; Osawa S; Koizumi H; Miyajima Y; Fujii K
    No Shinkei Geka; 2010 Feb; 38(2):133-7. PubMed ID: 20166525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal dysfunction during and after high-dose methotrexate.
    Green MR; Chamberlain MC
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in individual prediction of methotrexate toxicity: a review.
    Schmiegelow K
    Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.
    Peyriere H; Poiree M; Cociglio M; Margueritte G; Hansel S; Hillaire-Buys D
    Med Pediatr Oncol; 2001 Jun; 36(6):662-4. PubMed ID: 11344503
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T; Costa V; Silva I; Oliva T; Norton L
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia].
    Cwliklińska M; Balwierz W; Nowak J; Stanuch H
    Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
    Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
    Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
    Tuffaha HW; Al Omar S
    J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral erythema with oral methotrexate in a child.
    Varela CR; McNamara J; Antaya RJ
    Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.
    Van Hest RM; Schnog JB; Van't Veer MB; Cornelissen JJ
    Am J Hematol; 2008 Sep; 83(9):757-8. PubMed ID: 18615671
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management recommendations in patients with methotrexate intoxication].
    Schellens JH; Beijnen JH
    Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.